Unaudited Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Sep. 30, 2022	Jun. 30, 2022
Current assets:
Cash and cash equivalents		$ 81,007	$ 88,737
Restricted cash		203	204
Accounts receivable, net of allowance for credit losses of $848 and $1,000 as of September 30, 2022 and June 30, 2022, respectively (a)	[1]	77,029	94,442
Inventories		152,624	142,254
Prepaid expenses and other current assets (b)	[2]	24,241	23,794
Deferred cost of revenue		161	1,459
Total current assets		335,265	350,890
Property and equipment, net		10,938	12,685
Investment in joint venture		12,776	13,879
Operating lease right-of-use assets, net		26,789	16,798
Goodwill		57,658	57,840
Intangible assets, net		214	250
Long-term restricted cash		1,180	1,213
Other assets		21,529	19,294
Total assets		466,349	472,849
Current liabilities:
Accounts payable		32,945	31,337
Accrued compensation		30,890	29,441
Operating lease liabilities, current		4,864	8,567
Other accrued liabilities		30,201	30,285
Customer advances		17,983	25,290
Deferred revenue		69,948	75,375
Short-term debt		5,705	8,563
Total current liabilities		192,536	208,858
Long-term liabilities:
Operating lease liabilities, non-current		24,123	10,453
Long-term other liabilities		3,626	3,748
Deferred revenue, non-current		28,453	24,694
Long-term debt		170,620	171,907
Total liabilities		419,358	419,660
Commitments and contingencies (Note 9)
Stockholders' equity:
Common stock, $0.001 par value; authorized: 200,000,000 shares as of September 30, 2022 and June 30, 2022, respectively; issued and outstanding: 93,778,769 and 93,499,500 shares at September 30, 2022 and June 30, 2022, respectively		94	94
Additional paid-in-capital		546,117	543,211
Accumulated other comprehensive income (loss)		(1,249)	2,406
Accumulated deficit		(497,971)	(492,522)
Total stockholders' equity		46,991	53,189
Total liabilities and stockholders' equity		$ 466,349	$ 472,849

[1] Includes trade receivable from the China joint venture, an equity method investment of $18,591 and $24,828 at September 30, 2022 and June 30, 2022, respectively. See Note 14.

[2] Includes other receivable from the China joint venture, an equity method investment of $779 and $861 at September 30, 2022 and June 30, 2022, respectively.